Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS
Cutaneous aspergillosis occurs infrequently among HIV-infected patients; previous reports describe a total of seven patients with primary cutaneous aspergillosis [1-5]. Thus far, however, the risk factors, expected outcome, and therapeutic approach have not been defined for HIV-infected patients wit...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 1998-09, Vol.27 (3), p.643-644 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 644 |
|---|---|
| container_issue | 3 |
| container_start_page | 643 |
| container_title | Clinical infectious diseases |
| container_volume | 27 |
| creator | van Burik, Jo-Anne H. Colven, Roy Spach, David H. |
| description | Cutaneous aspergillosis occurs infrequently among HIV-infected patients; previous reports describe a total of seven patients with primary cutaneous aspergillosis [1-5]. Thus far, however, the risk factors, expected outcome, and therapeutic approach have not been defined for HIV-infected patients with primary cutaneous aspergillosis. We describe tow cases of primary cutaneous aspergillosis in patients with AIDS who were treated with itraconazole, and we present our approach to the diagnosis and management of cutaneous aspergillosis. |
| doi_str_mv | 10.1086/517138 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69968695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4460600</jstor_id><sourcerecordid>4460600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-61b2efb9fe52dd5c5259a591835fb12d734ed33b0b549ac443b5b1c11c1e90b93</originalsourceid><addsrcrecordid>eNqFkE1rGzEQhkVISfP5CxrQofS2qbTa0cfROG1iMKkhKYRehKTVJkrXu44k0zq_PmvWuMfCwAw8D8PLi9AFJVeUSP4VqKBMHqBjCkwUHBQ9HG4Csqgkkx_RSUovhFAqCRyhIyUEoVwdo7tZjsb1nXnrW48fnn00qw1u-ogXMSxN3ODpOpvO9-uEJ2nl41No2z6FhEOHFyYH3-WE_4T8jCez6_sz9KExbfLnu32Kfn7_9jC9LeY_bmbTybxwVQm54NSWvrGq8VDWNTgoQZkhsmTQWFrWglW-ZswSC5UyrqqYBUsdHcYrYhU7RV_Gv6vYv659ynoZkvNtO0bVXCkuuYL_ilSUUoAg_0QX-5Sib_RqLEBTorcN67HhQbzcfVzbpa_32q7SgX_ecZOcaZtoOhfSXiuZUJJug30atZeU-7jHVcUJJ9s4xYhDyv7vHpv4W3PBBOjbx1_6EdTd_EYSvWDvR-6Ztw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17287570</pqid></control><display><type>article</type><title>Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>van Burik, Jo-Anne H. ; Colven, Roy ; Spach, David H.</creator><creatorcontrib>van Burik, Jo-Anne H. ; Colven, Roy ; Spach, David H.</creatorcontrib><description>Cutaneous aspergillosis occurs infrequently among HIV-infected patients; previous reports describe a total of seven patients with primary cutaneous aspergillosis [1-5]. Thus far, however, the risk factors, expected outcome, and therapeutic approach have not been defined for HIV-infected patients with primary cutaneous aspergillosis. We describe tow cases of primary cutaneous aspergillosis in patients with AIDS who were treated with itraconazole, and we present our approach to the diagnosis and management of cutaneous aspergillosis.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/517138</identifier><identifier>PMID: 9770169</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University Chicago Press</publisher><subject>Adhesives ; AIDS ; AIDS-Related Opportunistic Infections - drug therapy ; AIDS-Related Opportunistic Infections - immunology ; AIDS-Related Opportunistic Infections - pathology ; AIDS/HIV ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal agents ; Antifungal Agents - therapeutic use ; Aspergillosis ; Aspergillosis - complications ; Aspergillosis - drug therapy ; Aspergillosis - immunology ; Aspergillosis - pathology ; Aspergillus ; Biological and medical sciences ; Biopsies ; Brief Reports ; Catheters ; CD4 Lymphocyte Count ; Dermatomycoses - complications ; Dermatomycoses - drug therapy ; Dermatomycoses - immunology ; Forearm ; Human immunodeficiency virus ; Humans ; Itraconazole - therapeutic use ; Lesions ; Medical sciences ; Neutropenia ; Nodules ; Peripheral catherization ; Pharmacology. Drug treatments</subject><ispartof>Clinical infectious diseases, 1998-09, Vol.27 (3), p.643-644</ispartof><rights>Copyright 1998 The Infectious Diseases Society of America</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-61b2efb9fe52dd5c5259a591835fb12d734ed33b0b549ac443b5b1c11c1e90b93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4460600$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4460600$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2379815$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9770169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Burik, Jo-Anne H.</creatorcontrib><creatorcontrib>Colven, Roy</creatorcontrib><creatorcontrib>Spach, David H.</creatorcontrib><title>Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><description>Cutaneous aspergillosis occurs infrequently among HIV-infected patients; previous reports describe a total of seven patients with primary cutaneous aspergillosis [1-5]. Thus far, however, the risk factors, expected outcome, and therapeutic approach have not been defined for HIV-infected patients with primary cutaneous aspergillosis. We describe tow cases of primary cutaneous aspergillosis in patients with AIDS who were treated with itraconazole, and we present our approach to the diagnosis and management of cutaneous aspergillosis.</description><subject>Adhesives</subject><subject>AIDS</subject><subject>AIDS-Related Opportunistic Infections - drug therapy</subject><subject>AIDS-Related Opportunistic Infections - immunology</subject><subject>AIDS-Related Opportunistic Infections - pathology</subject><subject>AIDS/HIV</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Aspergillosis</subject><subject>Aspergillosis - complications</subject><subject>Aspergillosis - drug therapy</subject><subject>Aspergillosis - immunology</subject><subject>Aspergillosis - pathology</subject><subject>Aspergillus</subject><subject>Biological and medical sciences</subject><subject>Biopsies</subject><subject>Brief Reports</subject><subject>Catheters</subject><subject>CD4 Lymphocyte Count</subject><subject>Dermatomycoses - complications</subject><subject>Dermatomycoses - drug therapy</subject><subject>Dermatomycoses - immunology</subject><subject>Forearm</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Itraconazole - therapeutic use</subject><subject>Lesions</subject><subject>Medical sciences</subject><subject>Neutropenia</subject><subject>Nodules</subject><subject>Peripheral catherization</subject><subject>Pharmacology. Drug treatments</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1rGzEQhkVISfP5CxrQofS2qbTa0cfROG1iMKkhKYRehKTVJkrXu44k0zq_PmvWuMfCwAw8D8PLi9AFJVeUSP4VqKBMHqBjCkwUHBQ9HG4Csqgkkx_RSUovhFAqCRyhIyUEoVwdo7tZjsb1nXnrW48fnn00qw1u-ogXMSxN3ODpOpvO9-uEJ2nl41No2z6FhEOHFyYH3-WE_4T8jCez6_sz9KExbfLnu32Kfn7_9jC9LeY_bmbTybxwVQm54NSWvrGq8VDWNTgoQZkhsmTQWFrWglW-ZswSC5UyrqqYBUsdHcYrYhU7RV_Gv6vYv659ynoZkvNtO0bVXCkuuYL_ilSUUoAg_0QX-5Sib_RqLEBTorcN67HhQbzcfVzbpa_32q7SgX_ecZOcaZtoOhfSXiuZUJJug30atZeU-7jHVcUJJ9s4xYhDyv7vHpv4W3PBBOjbx1_6EdTd_EYSvWDvR-6Ztw</recordid><startdate>19980901</startdate><enddate>19980901</enddate><creator>van Burik, Jo-Anne H.</creator><creator>Colven, Roy</creator><creator>Spach, David H.</creator><general>The University Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>19980901</creationdate><title>Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS</title><author>van Burik, Jo-Anne H. ; Colven, Roy ; Spach, David H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-61b2efb9fe52dd5c5259a591835fb12d734ed33b0b549ac443b5b1c11c1e90b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adhesives</topic><topic>AIDS</topic><topic>AIDS-Related Opportunistic Infections - drug therapy</topic><topic>AIDS-Related Opportunistic Infections - immunology</topic><topic>AIDS-Related Opportunistic Infections - pathology</topic><topic>AIDS/HIV</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Aspergillosis</topic><topic>Aspergillosis - complications</topic><topic>Aspergillosis - drug therapy</topic><topic>Aspergillosis - immunology</topic><topic>Aspergillosis - pathology</topic><topic>Aspergillus</topic><topic>Biological and medical sciences</topic><topic>Biopsies</topic><topic>Brief Reports</topic><topic>Catheters</topic><topic>CD4 Lymphocyte Count</topic><topic>Dermatomycoses - complications</topic><topic>Dermatomycoses - drug therapy</topic><topic>Dermatomycoses - immunology</topic><topic>Forearm</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Itraconazole - therapeutic use</topic><topic>Lesions</topic><topic>Medical sciences</topic><topic>Neutropenia</topic><topic>Nodules</topic><topic>Peripheral catherization</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Burik, Jo-Anne H.</creatorcontrib><creatorcontrib>Colven, Roy</creatorcontrib><creatorcontrib>Spach, David H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Burik, Jo-Anne H.</au><au>Colven, Roy</au><au>Spach, David H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clinical Infectious Diseases</addtitle><date>1998-09-01</date><risdate>1998</risdate><volume>27</volume><issue>3</issue><spage>643</spage><epage>644</epage><pages>643-644</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Cutaneous aspergillosis occurs infrequently among HIV-infected patients; previous reports describe a total of seven patients with primary cutaneous aspergillosis [1-5]. Thus far, however, the risk factors, expected outcome, and therapeutic approach have not been defined for HIV-infected patients with primary cutaneous aspergillosis. We describe tow cases of primary cutaneous aspergillosis in patients with AIDS who were treated with itraconazole, and we present our approach to the diagnosis and management of cutaneous aspergillosis.</abstract><cop>Chicago, IL</cop><pub>The University Chicago Press</pub><pmid>9770169</pmid><doi>10.1086/517138</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 1998-09, Vol.27 (3), p.643-644 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69968695 |
| source | MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals |
| subjects | Adhesives AIDS AIDS-Related Opportunistic Infections - drug therapy AIDS-Related Opportunistic Infections - immunology AIDS-Related Opportunistic Infections - pathology AIDS/HIV Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal agents Antifungal Agents - therapeutic use Aspergillosis Aspergillosis - complications Aspergillosis - drug therapy Aspergillosis - immunology Aspergillosis - pathology Aspergillus Biological and medical sciences Biopsies Brief Reports Catheters CD4 Lymphocyte Count Dermatomycoses - complications Dermatomycoses - drug therapy Dermatomycoses - immunology Forearm Human immunodeficiency virus Humans Itraconazole - therapeutic use Lesions Medical sciences Neutropenia Nodules Peripheral catherization Pharmacology. Drug treatments |
| title | Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A22%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Itraconazole%20Therapy%20for%20Primary%20Cutaneous%20Aspergillosis%20in%20Patients%20with%20AIDS&rft.jtitle=Clinical%20infectious%20diseases&rft.au=van%20Burik,%20Jo-Anne%20H.&rft.date=1998-09-01&rft.volume=27&rft.issue=3&rft.spage=643&rft.epage=644&rft.pages=643-644&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/517138&rft_dat=%3Cjstor_proqu%3E4460600%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17287570&rft_id=info:pmid/9770169&rft_jstor_id=4460600&rfr_iscdi=true |